Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Infectious Diseases

• Publication date

  2010-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/651262PMID 20218876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HLA and Infectious Diseases

  2009cited by this paper
• Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

  2008cited by this paper
• CD4+CD25+FOXP3+ Regulatory T Cells Increase De Novo in Kidney Transplant Patients After Immunodepletion with Campath‐1H

  2008cited by this paper
• Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients

  2008cited by this paper
• Comparison of the Use of Administrative Data and an Active System for Surveillance of Invasive Aspergillosis

  2008cited by this paper
• Campath Induction for Kidney Transplantation: Report of 297 Cases

  2008cited by this paper
• Fungal infections in solid organ transplantation.

  2007influential reference
• Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

  2007cited by this paper
• Aspergillus infection in lung transplant patients: incidence and prognosis

  2007cited by this paper
• Anidulafungin versus fluconazole for invasive candidiasis.

  2007cited by this paper
• Incidence of fungal infections in a solid organ recipients dedicated intensive care unit.

  2007cited by this paper
• Invasive candidiasis.

  2006cited by this paper
• Voriconazole Prophylaxis in Lung Transplant Recipients

  2006cited by this paper
• Inhaled Amphotericin B for Prophylaxis Against Invasive Aspergillus Infections

  2006cited by this paper
• Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center

  2005cited by this paper
• Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

  2005cited by this paper
• Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study.

  2005cited by this paper
• Calcineurin Inhibitor- and Steroid-Free Immunosuppression in Pancreas-Kidney and Solitary Pancreas Transplantation

  2005cited by this paper
• Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients.

  2005cited by this paper
• Antifungal agents for preventing fungal infections in solid organ transplant recipients.

  2004cited by this paper
• Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

  2004cited by this paper
• Donor-related coccidioidomycosis in organ transplant recipients.

  2003cited by this paper
• Fungal infections in the recipients of solid organ transplantation.

  2003influential reference
• Longitudinal study of cryptococcosis in adult solid-organ transplant recipients

  2003cited by this paper
• Asymptomatic pulmonary cryptococcosis in solid organ transplantation: report of four cases and review of the literature

  2003cited by this paper
• Cryptococcosis in Organ Transplant Recipients: An Overview

  2002cited by this paper
• Risk factors for invasive aspergillosis in liver transplant recipients

  2002cited by this paper
• The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants

  2002cited by this paper
• Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome.

  2001cited by this paper
• Infections in recipients of kidney transplants.

  2001cited by this paper
• Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy.

  2000cited by this paper
• Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients

  2000cited by this paper
• Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients.

  2000cited by this paper
• Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.

  1996cited by this paper
• Infectious complications after small bowel transplantation in adults: an update.

  1996cited by this paper
• Fungal infections in solid organ transplant recipients.

  1995cited by this paper
• Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

  1994cited by this paper
• Fungal infections in solid-organ transplantation.

  1993cited by this paper

• Invasive aspergillosis in lung and heart transplant recipients.

  2026cites this paper
• Management of fusariosis in transplant patients

  2026influential citation
• Invasive aspergillosis in liver transplant recipients in France (2007-21): a nationwide, retrospective, matched case-control study.

  2026cites this paper
• Update on the diagnosis, pathophysiology and treatment strategies in non-HIV-associated cryptococcal meningoencephalitis

  2026cites this paper
• Population Pharmacokinetic and Pharmacodynamic Analysis of Voriconazole‐Induced Liver Injury in Chinese Lung Transplant Patients

  2026cites this paper
• Infections in Liver Retransplantation: A Prospective Study of Microbial Patterns, Immune Biomarkers, and Survival.

  2026cites this paper
• Subcutaneous abscess caused by Chondrostereum purpureum, an unusual infection from plant to human: The first case report in a transplant recipient

  2026cites this paper
• Optimizing Linezolid Dosing in Lung Transplant Recipients: Population Pharmacokinetics, Target Attainment, and Thrombocytopenia Risk Assessment

  2026cites this paper
• The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us

  2026cites this paper
• Mucormycosis.

  2026cites this paper
• One-Year Clinical, Radiological, and Functional Outcomes Following Antifungal Therapy for Aspergillus Infection in Lung Transplant Recipients

  2026cites this paper
• Discovery and Structural Optimization of Spirodioxynaphthalene-Based Mdr1 Efflux Pump Inhibitor to Combat Azole Resistance in Candida albicans.

  2026cites this paper
• Infections fongiques invasives chez les patients transplantés d’organe solide en 2026

  2026cites this paper
• High prevalence of azole resistance among environmental Aspergillus fumigatus isolates from outdoor air in Madrid, Spain

  2026cites this paper
• Challenges posed by fungi to host immunity: Mechanisms of immune evasion

  2026cites this paper
• Evaluation of an in vivo pulmonary aspergillosis model for triazole susceptibility breakpoint development

  2026cites this paper
• Invasive mold infection in heart transplant recipients: a nationwide multicenter matched case-control study between 2008 and 2022 in France.

  2026cites this paper
• Antifungal potential of entomopathogenic bacteria, Photorhabdus, and Xenorhabdus (Morganellaceae) against pathogenic fungi

  2025cites this paper
• Clinical experience of primary subcutaneous mycoses in Shanghai: a retrospective analysis

  2025cites this paper
• Donor-derived Scedosporium infection following deceased donor kidney transplantation presenting as endogenous endophthalmitis

  2025cites this paper
• Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for Individualized Immune-Based Strategies.

  2025cites this paper
• Hemorrhage Incognito

  2025cites this paper
• Clinical Utility of Molecular Diagnostics for Invasive Fungal Diseases.

  2025cites this paper
• Management of Invasive Pulmonary Aspergillosis in Intensive Care Units: Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS)

  2025cites this paper
• Non-Aspergillus invasive mould infections in liver transplant recipients : a French national retrospective case-control study, 2007 to 2021.

  2025cites this paper
• Preventing Invasive Aspergillosis in Lung Transplant Recipients: A Cost-Utility Analysis.

  2025cites this paper
• Fungal Infections in Kidney Transplant Recipients: A Comprehensive Narrative Review

  2025cites this paper
• Assessing the appropriateness of antifungal prescribing: key results from the implementation of a novel audit tool in Australian hospitals.

  2025cites this paper
• Appraisal of guidelines and variations in recommendations on drug therapy for invasive aspergillosis prevention and treatment

  2025cites this paper
• Signaling Pathways Regulating Dimorphism in Medically Relevant Fungal Species

  2025cites this paper
• Factors Associated with Candidemia After Living Donor Liver Transplantation: A Case–Control Study

  2025cites this paper
• Active and Passive Immunization of Pan-Fungal Vaccine NXT-2 Reduces Morbidity and Mortality in an Immunosuppressed Murine Model of Candida auris Systemic Infection

  2025cites this paper
• Infection Transmission Through Organ Preservation Solutions

  2025cites this paper
• The Unnoticed Threat: Clinical Characteristics, Risk Factors, and Outcome of Mucormycosis in Solid Organ Transplantation

  2025cites this paper
• Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure

  2025cites this paper
• Towards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults.

  2025cites this paper
• The Prevalence and Drug Susceptibility of Candida Species and an Analysis of Risk Factors for Oral Candidiasis—A Retrospective Study

  2025cites this paper
• The INTERACT Study - Infection Prevention and Surveillance Practice in the care of the Australasian Cancer and Transplant Population.

  2025cites this paper
• CT Findings for Differentiating Pulmonary Mucormycosis From Invasive Pulmonary Aspergillosis, Prior to Invasive Procedure Such as a Biopsy or Surgery: A 22‐Year Single‐Center Experience

  2025cites this paper
• Cryptococcus: Emerging host risk factors for infection

  2025influential citation
• Antifungal use and appropriateness: a study of Australian Hospital National Antimicrobial Prescribing Survey data

  2025cites this paper
• Cryptococcosis in kidney transplant recipients: Pathogenesis, clinical challenges, and evolving therapeutic strategies.

  2025cites this paper
• Plasma Cell-free DNA Associated With Risk of Mortality and Chronic Lung Allograft Dysfunction Among Lung Transplant Recipients With Aspergillus

  2025cites this paper
• Mucorales PCR Testing in Respiratory and Biopsy Samples From Immunocompromised Patients With Invasive Pulmonary Aspergillosis and Other Mold Infections: Results From a Multicenter ECMM Study

  2025cites this paper
• Establishment and validation of a predictive nomogram for voriconazole-associated liver injury in lung transplant patients

  2025influential citation
• S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025

  2025cites this paper
• Healthcare Resource Utilization, Treatment Costs, and Mortality in Patients with Malignancies or Transplantation Who Develop Invasive Aspergillosis

  2025cites this paper
• Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC

  2025influential citation
• Cryptococcosis in Pediatric Renal Transplant Recipients: Comparative Insights from Adult Cases

  2025cites this paper
• Genetics and humoral responses of the immune system to Aspergillus fumigatus.

  2025cites this paper
• Fungal Infections in Transplant Recipients Pre- and Post-coronavirus Disease 2019: Results from a Single-Center Retrospective Cohort Study

  2025influential citation
• Practical Guide on the Use of Induction Immunosuppression in Heart Transplantation.

  2025cites this paper
• Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program

  2025cites this paper
• High Mortality and Associated Risk Factors in Kidney Transplant Recipients With Cryptococcosis—A Nationwide Cohort Study Over a Decade Using USRDS Data

  2025cites this paper
• Central Nervous System Infections in Recipients of Solid Organ Transplant.

  2025cites this paper
• Concordance of non-invasive plasma cell-free DNA with invasive diagnostics for diagnosis of invasive fungal disease.

  2025cites this paper
• Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study

  2025cites this paper
• Respiratory infections in lung transplant recipients

  2025cites this paper
• Severe Disseminated Cryptococcosis Leading to Multi-Organ Failure in a Renal Transplant Patient: A Case Report.

  2025cites this paper
• Invasive Aspergillosis in the Current Era.

  2025cites this paper
• Hyphal penetration is the major pathway of translocation of Candida albicans across the blood-cerebrospinal fluid barrier

  2025cites this paper
• Longitudinal Assessment of the Effect of Invasive Fungal Infections on Transplant Success in Kidney Transplant Recipients.

  2025cites this paper
• Early-Onset Candidemia in Adult Intensive Care Units

  2025cites this paper
• Invasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States

  2025influential citation
• Lead Optimization and Target Identification of Carboline Antifungal Agents.

  2025cites this paper
• Interaction between Dectin-1 gene polymorphisms and low weight on the risk of invasive pulmonary aspergillosis in patients with lung cancer undergoing surgery

  2025cites this paper
• Transplant Infectious Disease Training: Bridging the Gap

  2025cites this paper
• Increased fungal burden in the gastrointestinal tract of brain-dead organ donors

  2025cites this paper
• Dematiaceous Fungal Infections in Kidney Transplant Recipients – Case Series

  2025cites this paper
• Double Jeopardy: Cutaneous Mucormycosis in a Renal Transplant Patient Post-COVID-19

  2025cites this paper
• Aftercare of Solid Abdominal Organ Transplant Recipients.

  2025cites this paper
• Incidence and Risk Factors of Fungal Infections Within 3 Months Following Pediatric Liver Transplantation

  2025cites this paper
• Invasive Candida infections in solid organ transplant recipients between 2008 and 2020.

  2025cites this paper
• Invasive Fungal Infections in Orthotopic Heart Transplant Patients: Incidence and Risk Factors in the Modern Era

  2025cites this paper
• Invasive candidiasis following lung transplant: An Assessment of impact utilizing a national insurance claims cohort

  2025cites this paper
• Updates on Donor-Derived Infection in Solid Organ Transplantation, Report from the 2024 GTI (Infection and Transplantation Group) Annual Meeting

  2025cites this paper
• Cerebral Phaeohyphomycosis in a Liver Transplant Recipient – A Masquerader! A Case Report and Narrative Review of Literature

  2025cites this paper
• Managing Invasive Fungal Infections During Allogeneic Hematopoietic Transplantation: A 2025 Update

  2025cites this paper
• Brazilian task force for the management of mucormycosis

  2025influential citation
• Candida

  2025cites this paper
• Pretransplant screening for infections in lung and heart transplant candidates

  2025influential citation
• The changing epidemiology of invasive mold diseases in immunosuppressed patients: what, why, how?

  2025cites this paper
• Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO)

  2025cites this paper
• A Fatal Case of Disseminated Mucormycosis in a Patient Shortly after Starting Treatment Against Malignant Lymphoma.

  2025cites this paper
• Calcineurin-NFAT signaling controls neutrophils´ ability of chemoattraction upon fungal infection.

  2024cites this paper
• Epidemiological trends and clinical outcomes of cryptococcosis in a medically insured population in the United States: a claims-based analysis from 2017 to 2019

  2024cites this paper
• Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS)

  2024cites this paper
• Fusarium, Scedosporium and Other Rare Mold Invasive Infections: Over Twenty-Five-Year Experience of a European Tertiary-Care Center

  2024cites this paper
• Drug–drug interaction between tacrolimus and caspofungin in Chinese kidney transplant patients with different CYP3A5 genotypes

  2024cites this paper
• A secondary mechanism of action for triazole antifungals in Aspergillus fumigatus mediated by hmg1

  2024cites this paper
• Epithelial uptake leads to fungal killing in vivo and is aberrant in COPD-derived epithelial cells

  2024cites this paper
• Incidence, causative organisms, and risk factors of bloodstream infections in pediatric liver transplant patients: a systematic review

  2024cites this paper
• The epidemiology of fungal infections in transplant patients.

  2024cites this paper
• Solid organ transplant-related central nervous system infections

  2024cites this paper
• An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients Taking Belatacept for Organ Rejection Prophylaxis: A Single-Center Retrospective Cohort Study

  2024cites this paper
• cyp51A mutations, protein modeling, and efflux pump gene expression reveals multifactorial complexity towards understanding Aspergillus section Nigri azole resistance mechanism

  2024cites this paper
• PCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic?

  2024influential citation
• Pharmacological management of invasive mold infections in solid organ transplant recipients

  2024cites this paper
• Voriconazole-induced periostitis in a lung transplant recipient

  2024cites this paper
• Genome-based solutions for managing mucormycosis.

  2024cites this paper